Research Project
Grant-in-Aid for Scientific Research (C)
Elevated levels of high-density lipoprotein cholesterol (HDL-C) reduce the risk of coronary artery disease. HDL is known to exhibit anti-atherogenic effects by multiple mechanisms such as cholesterol efflux from atherosclerotic plaque, anti-inflammatory, and antioxidant effects. Here we showed that apoA-I binding protein (AIBP), which potentially interact with HDL in plasma, exert an anti-atherosclerotic effects by enhancing the HDL ability of promoting lipid efflux and anti-inflammation. Our findings uncovered a novel role of AIBP in atherosclerosis.
HDLが上昇することで、形成された病変が縮小する動脈硬化の治療効果が期待できることから、HDL創薬の社会的・医療経済的意義は大きい。本研究によって得られた知見は、これまでほとんど機能未知だったAIBPの生理的な作用について明らかにしており、学術的意義のみならず、HDL創薬への新しい可能性を示したという点で、それに応えるものである。
All 2019 2018 2017 2016 Other
All Int'l Joint Research (1 results) Journal Article (21 results) (of which Int'l Joint Research: 8 results, Peer Reviewed: 21 results, Open Access: 6 results, Acknowledgement Compliant: 4 results) Presentation (19 results) (of which Int'l Joint Research: 1 results, Invited: 1 results) Remarks (5 results)
Biological and Pharmaceutical Bulletin
Volume: 42 Issue: 6 Pages: 1019-1024
10.1248/bpb.b19-00114
130007657697
International Journal of Pharmaceutics
Volume: 564 Pages: 256-262
10.1016/j.ijpharm.2019.04.054
Molecules
Volume: 24 Issue: 9 Pages: 1689-1689
10.3390/molecules24091689
120006995454
European Journal of Pharmaceutics and Biopharmaceutics
Volume: 145 Pages: 27-34
10.1016/j.ejpb.2019.10.005
IUBMB Life
Volume: 72 Issue: 4 Pages: 641-651
10.1002/iub.2203
Volume: 41 Issue: 7 Pages: 1078-1083
10.1248/bpb.b18-00202
130007387206
Volume: 41 Issue: 5 Pages: 733-742
10.1248/bpb.b17-00919
130006730692
J. Control Release
Volume: 270 Pages: 114-119
10.1016/j.jconrel.2017.12.002
Mol Pharm.
Volume: 15 Issue: 2 Pages: 403-409
10.1021/acs.molpharmaceut.7b00762
Volume: 127 Pages: 142-149
10.1016/j.ejpb.2018.02.019
Journal of Biological Chemistry
Volume: 293 Issue: 18 Pages: 6776-6790
10.1074/jbc.ra117.001091
Scientific Reports
Volume: 8 Issue: 1 Pages: 5497-5497
10.1038/s41598-018-23920-3
Volume: 8 Issue: 1 Pages: 14493-14493
10.1038/s41598-018-32861-w
120006875666
Pharmaceutical Research
Volume: 35 Issue: 11 Pages: 223-223
10.1007/s11095-018-2505-3
The Journal of Immunology
Volume: 201 Issue: 10 Pages: 2969-2976
10.4049/jimmunol.1701351
J Biol Chem
Volume: 292 Issue: 11 Pages: 4556-4570
10.1074/jbc.m116.768853
Biomaterials.
Volume: 140 Pages: 162-169
10.1016/j.biomaterials.2017.06.021
Mol pharmacol
Volume: 91 Issue: 3 Pages: 159-166
10.1124/mol.116.105569
J. Peptide Sci.
Volume: 22 Issue: 2 Pages: 116-122
10.1002/psc.2847
Bioorg Med Chem Lett.
Volume: 26 Issue: 11 Pages: 2655-2658
10.1016/j.bmcl.2016.04.013
Sci. Rep.
Volume: 6 Issue: 1 Pages: 30391-30391
10.1038/srep30391
120006534966
http://pub2.db.tokushima-u.ac.jp/ERD/person/279489/profile-ja.html
https://www.tokushima-u.ac.jp/ph/faculty/labo/szi/
http://pub2.db.tokushima-u.ac.jp/ERD/person/279489/work-ja.html
http://www.tokushima-u.ac.jp/ph/faculty/labo/szi/
http://www.tokushima-u.ac.jp/ph/faculty/labo/szi/achivement.html